Dihydro β erythroidine dhβe
Dihydro-β-erythroidine (DHβE) is a laboratory reagent used in research applications. It functions as a selective antagonist for nicotinic acetylcholine receptors. The core purpose of this compound is to facilitate the study of nicotinic receptor physiology and pharmacology in experimental settings.
Lab products found in correlation
7 protocols using dihydro β erythroidine dhβe
Cembranoid 4R Preparation and Characterization
Electrophysiological Assay for Cholinergic Compounds
Neurotransmitter Receptor Ligand Acquisition
Pharmacological Modulation of Nicotinic Receptors
Nicotine-free Receptor Pharmacology
Pharmacological Profiling of Receptor Interactions
Pharmacological Modulation of Nicotinic Receptors
RuBi-nicotine was obtained from Abcam. α-conotoxin MII (α-Ctx
MII) was synthesized as previously described30 (link),31 (link).
Acetylcholine (ACh), mecamylamine (mec), atropine, picrotoxin,
dihydro-β-erythroidine (DHβE), and all other chemicals without a
specified supplier were obtained from Sigma.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!